Home › Prostate Cancer › California › Santa Barbara
Prostate Cancer clinical trials in Santa Barbara, CA
3 studies for Prostate Cancer are looking for participants at sites in and around Santa Barbara (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RecruitingPhase 3
- UCLA Hematology/Oncology - Santa Barbara, Santa Barbara
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
RecruitingPhase 2/3
- Sansum Clinic, Santa Barbara
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RecruitingPhase 3
- Sansum Clinic, Santa Barbara
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA59 studies
- St. Louis, MO46 studies
- Chicago, IL45 studies
- San Francisco, CA45 studies
- Philadelphia, PA44 studies
- Baltimore, MD43 studies
- Nashville, TN43 studies
- Seattle, WA42 studies
- Washington, DC38 studies
Other studies in Santa Barbara
- Cancer (all types)7 studies
- Breast Cancer6 studies
- Non-Small Cell Lung Cancer5 studies
- Ovarian Cancer5 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
- Type 2 Diabetes3 studies
- Pulmonary Hypertension3 studies
- Pulmonary Arterial Hypertension3 studies
- Endometrial Cancer3 studies
- Bladder Cancer3 studies
- Metastatic Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.